129 related articles for article (PubMed ID: 25403516)
1. Enhanced antisense oligonucleotide delivery using cationic liposomes incorporating fatty acid-modified polyethylenimine.
Guo Z; Li Y; Fu Y; Guo T; Li X; Yang S; Xie J
Curr Pharm Biotechnol; 2014; 15(9):800-5. PubMed ID: 25403516
[TBL] [Abstract][Full Text] [Related]
2. Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery.
Yang S; Yang X; Liu Y; Zheng B; Meng L; Lee RJ; Xie J; Teng L
Colloids Surf B Biointerfaces; 2015 Nov; 135():274-282. PubMed ID: 26263216
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic assembly of lipid nanoparticles for delivery of antisense oligonucleotides.
Zhou Y; Meng Z; Guo T; Fu Y; Lee RJ; Xie J
Curr Pharm Biotechnol; 2014; 15(9):823-8. PubMed ID: 25335534
[TBL] [Abstract][Full Text] [Related]
4. A polyethylenimine-linoleic acid conjugate for antisense oligonucleotide delivery.
Xie J; Teng L; Yang Z; Zhou C; Liu Y; Yung BC; Lee RJ
Biomed Res Int; 2013; 2013():710502. PubMed ID: 23862153
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Antisense Oligonucleotide LOR-2501 Using Transferrin-conjugated Polyethylenimine-based Lipid Nanoparticle.
Zheng B; Yang S; Tian Q; Xie Y; Zhang S; Lee RJ
Anticancer Res; 2019 Apr; 39(4):1785-1793. PubMed ID: 30952718
[TBL] [Abstract][Full Text] [Related]
6. Delivery of antisense oligonucleotide using polyethylenimine-based lipid nanoparticle modified with cell penetrating peptide.
Yang S; Wang D; Sun Y; Zheng B
Drug Deliv; 2019 Dec; 26(1):965-974. PubMed ID: 31544540
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells.
Lee CH; Ni YH; Chen CC; Chou C; Chang FH
Biochim Biophys Acta; 2003 Apr; 1611(1-2):55-62. PubMed ID: 12659945
[TBL] [Abstract][Full Text] [Related]
8. A novel reduction-sensitive modified polyethylenimine oligonucleotide vector.
Yang S; Lee RJ; Yang X; Zheng B; Xie J; Meng L; Liu Y; Teng L
Int J Pharm; 2015 Apr; 484(1-2):44-50. PubMed ID: 25698089
[TBL] [Abstract][Full Text] [Related]
9. Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.
Meissner JM; Toporkiewicz M; Czogalla A; Matusewicz L; Kuliczkowski K; Sikorski AF
J Control Release; 2015 Dec; 220(Pt A):515-528. PubMed ID: 26585505
[TBL] [Abstract][Full Text] [Related]
10. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
[TBL] [Abstract][Full Text] [Related]
11. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
[TBL] [Abstract][Full Text] [Related]
12. Serum-resistant lipopolyplexes for gene delivery to liver tumour cells.
García L; Buñuales M; Düzgüneş N; Tros de Ilarduya C
Eur J Pharm Biopharm; 2007 Aug; 67(1):58-66. PubMed ID: 17321729
[TBL] [Abstract][Full Text] [Related]
13. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides.
Han SE; Kang H; Shim GY; Kim SJ; Choi HG; Kim J; Hahn SK; Oh YK
J Drug Target; 2009 Feb; 17(2):123-32. PubMed ID: 19012052
[TBL] [Abstract][Full Text] [Related]
14. Endocytic Transport of Polyplex and Lipoplex siRNA Vectors in HeLa Cells.
Lazebnik M; Keswani RK; Pack DW
Pharm Res; 2016 Dec; 33(12):2999-3011. PubMed ID: 27585903
[TBL] [Abstract][Full Text] [Related]
15. Enhanced siRNA delivery using oleic acid derivative of polyethylenimine.
Teng L; Xie J; Teng L; Lee RJ
Anticancer Res; 2012 Apr; 32(4):1267-71. PubMed ID: 22493358
[TBL] [Abstract][Full Text] [Related]
16. Formulation and delivery of splice-correction antisense oligonucleotides by amino acid modified polyethylenimine.
Zaghloul EM; Viola JR; Zuber G; Smith CI; Lundin KE
Mol Pharm; 2010 Jun; 7(3):652-63. PubMed ID: 20128628
[TBL] [Abstract][Full Text] [Related]
17. Transfection Efficiency Evaluation and Endocytosis Exploration of Different Polymer Condensed Agents.
Wang J; Ye X; Ni H; Zhang J; Ju S; Ding W
DNA Cell Biol; 2019 Oct; 38(10):1048-1055. PubMed ID: 31433200
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide.
Li H; Liu Y; Chen L; Liu Q; Qi S; Cheng X; Lee YB; Ahn CH; Kim DJ; Lee RJ
J Drug Target; 2018; 26(5-6):466-473. PubMed ID: 29376449
[TBL] [Abstract][Full Text] [Related]
19. Lipopolyplexes as nanomedicines for therapeutic gene delivery.
García L; Urbiola K; Düzgüneş N; Tros de Ilarduya C
Methods Enzymol; 2012; 509():327-38. PubMed ID: 22568913
[TBL] [Abstract][Full Text] [Related]
20. MRI-visible liposome-polyethylenimine complexes for DNA delivery: preparation and evaluation.
Song X; Yan G; Quan S; Jin E; Quan J; Jin G
Biosci Biotechnol Biochem; 2019 Apr; 83(4):622-632. PubMed ID: 30585119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
